Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Effect of Benralizumab vs Mepolizumab on Reduction...
Conference

Effect of Benralizumab vs Mepolizumab on Reduction in Oral Glucocorticoid (OGC) Use in Eosinophilic Granulomatosis with Polyangiitis (EGPA)

Authors

Hellmich B; Wechsler ME; Merkel PA; Nair P; Bourdin A; Jayne DRW; Roufosse F; Sjo LB; Fan Y; Menzies-Gow A

Volume

154

Pagination

pp. 6S-6S

Publisher

SMW supporting association

Publication Date

September 9, 2024

Conference proceedings

SWISS MEDICAL WEEKLY

ISSN

1424-7860

Labels

Fields of Research (FoR)